BERGANTINI LAURA | Professor page

Perea, B., Gambini, C., Paggi, I., Biancucci, S., Cattelan, S., Genovese, M., et al. (2026). Adding pieces to the puzzle: IL-33 contribution to fibrogenesis in chronic lung allograft dysfunction. CYTOKINE, 197 [10.1016/j.cyto.2025.157080]. - view more
Vietri, L., D'Alessandro, M., Casolari, P., Lo Monaco, A., Reginato, M., Marchi, I., et al. (2025). SAA and lipid metabolism in IPF. ARCHIVES OF CLINICAL AND BIOMEDICAL RESEARCH, 9(3), 242-254 [10.26502/acbr.50170458]. - view more
Fontana, A., Bergantini, L., Carullo, G., Scalvini, L., D'Alessandro, M., Papulino, C., et al. (2025). Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 8(2), 380-393 [10.1021/acsptsci.4c00456]. - view more
Molino, C., Bergantini, L., Santucci, S., Pitinca, M.T., D'Alessandro, M., Cameli, P., et al. (2025). SARS-CoV-2 and Dysphagia: A Retrospective Analysis of COVID-19 Patients with Swallowing Disorders. DYSPHAGIA, 40(1), 162-168 [10.1007/s00455-024-10715-0]. - view more
Conticini, E., Cameli, P., Grazzini, S., D'Alessandro, M., Bergantini, L., Pianigiani, T., et al. (2025). Efficacy and safety of rituximab and low dosage of glucocorticoids for ANCA associated vasculitis interstitial lung disease: a proof-of-concept study. RESPIRATORY MEDICINE, 248 [10.1016/j.rmed.2025.108334]. - view more